SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1. Read more about SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.
SETDB1 Triple Tudor Domain Ligand, (R,R)-59, Promotes Methylation of Akt1 in Cells. Read more about SETDB1 Triple Tudor Domain Ligand, (R,R)-59, Promotes Methylation of Akt1 in Cells.
Developing a Kinase Chemogenomic Set: Facilitating Investigation into Kinase Biology by Linking Phenotypes to Targets. Read more about Developing a Kinase Chemogenomic Set: Facilitating Investigation into Kinase Biology by Linking Phenotypes to Targets.
Quality Control of Chemogenomic Library Using LC-MS. Read more about Quality Control of Chemogenomic Library Using LC-MS.
Annotation of the Effect of Chemogenomic Compounds on Cell Health Using High-Content Microscopy in Live-Cell Mode. Read more about Annotation of the Effect of Chemogenomic Compounds on Cell Health Using High-Content Microscopy in Live-Cell Mode.
Characterization of Cellular Viability Using Label-Free Brightfield Live-Cell Imaging. Read more about Characterization of Cellular Viability Using Label-Free Brightfield Live-Cell Imaging.
Measuring Protein-Protein Interactions in Cells using Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET) Assay. Read more about Measuring Protein-Protein Interactions in Cells using Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET) Assay.
HiBiT Cellular Thermal Shift Assay (HiBiT CETSA). Read more about HiBiT Cellular Thermal Shift Assay (HiBiT CETSA).
3D Spheroid Invasion Assay for High-Throughput Screening of Small-Molecule Libraries. Read more about 3D Spheroid Invasion Assay for High-Throughput Screening of Small-Molecule Libraries.
Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains. Read more about Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains.
